Clinical trial Recruiting at 9 sites Phase 3 Interventional Ages 18 and up

Comparing oral and intravenous antibiotics for treating infected nonunion of fractures

Official title: PO Versus IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

Run by Major Extremity Trauma Research Consortium · NCT05699174 · Data updated 2026-11-12

This study is testing whether taking antibiotics by mouth works as well as getting them through an IV for people with infected fractures that haven't healed properly after surgery.

More Fracture trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment250 (estimated)
SponsorMajor Extremity Trauma Research Consortium
Academic / other
Locations13 sites (Indianapolis, Indiana and 12 other locations)
StatusRecruiting
StartedMay 30, 2023
Main results expectedSeptember 2027
Study endsSeptember 29, 2028
Registry record updatedSeptember 11, 2026
Trial IDNCT05699174 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with an infected nonunion of a fracture that has undergone previous fixation.

Probably not a fit

Patients at high risk of amputation or those with significant comorbidities that prevent treatment with general anesthesia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase III clinical trial aims to compare the effectiveness of oral antibiotics versus intravenous antibiotics in treating infected nonunion of fractures after surgical fixation. The study will enroll 250 patients aged 18 and older who have experienced an infected nonunion following internal fixation of a fracture. Participants will be randomly assigned to receive either oral antibiotics for six weeks or intravenous antibiotics for the same duration. The primary outcome will assess clinical effectiveness based on the number of secondary re-admissions and treatment failures within one year, alongside other metrics such as treatment compliance and hospitalization duration.

Why it matters

Potential benefit: If successful, this study could provide a less invasive and more convenient oral antibiotic treatment option for patients with infected nonunion of fractures.

How similar studies have gone: Previous studies have shown promising results with oral antibiotics for various infections, but this specific comparison in the context of infected nonunion is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. 1\. Bone fracture (proximal to and including the tarsal/metatarsal joint (Lisfranc) or proximal to the carpal joints (includes distal radius fractures), excluding pelvis and spine) that has previously undergone fixation and has not healed and requires fixation to be retained or replaced at least until bone union. Fractures that have not healed and require revision fixation are also eligible.
2. Infection as determined by either

   1. FRI criteria
   2. CDC criteria (without the timeframe) This includes the possibility of culture negative, but determined to be infection by treating surgeon
3. Systemic antibiotic treatment regimen scheduled for at least 6 weeks

Exclusion Criteria:

1. Patients with a high risk of amputation based on the initial managing physician
2. Patients undergoing treatment of any other investigational therapy within the month preceding infection treatment or planned within the 12 months following infection treatment
3. Incarcerated or institutionalized patients
4. Patients who are unable to return for required follow-up visits and/or medical co-morbidities which preclude treatment with a general anesthetic
5. Patients with a prior history of chronic infection at the index site before fracture fixation
6. Patients with pathological fractures from a neoplastic process
7. History of Paget's Disease
8. The patient, or a designated proxy, unwilling to provide consent
9. The patient must be available for follow-up for at least 12 months following infection treatment

Where it's running

  • Indiana University
    Indianapolis, Indiana, United States
    Recruiting
  • University of Maryland , MD Department of Orthopaedics
    Baltimore, Maryland, United States
    Recruiting
  • Hennepin Health
    Minneapolis, Minnesota, United States
    Recruiting
  • Wake Forest University Baptist Medical Center
    Winston-Salem, North Carolina, United States
    Recruiting
  • Penn State University M.S. Hershey Medical Center
    Hershey, Pennsylvania, United States
    Recruiting
  • Vanderbilt Medical Center
    Nashville, Tennessee, United States
    Recruiting
Show 7 more locations
  • University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting
  • University of Washington Harborview Medical Center
    Seattle, Washington, United States
    Recruiting
  • University of Wisconsin
    Madison, Wisconsin, United States
    Recruiting
  • Sinai Hospital Baltimore
    Baltimore, Maryland, United States
    Not yet recruiting
  • Jamaica Hospital Medical Center
    Queens, New York, United States
    Not yet recruiting
  • Atrium Health, Carolinas Medical Center
    Charlotte, North Carolina, United States
    Not yet recruiting
  • University of Okalahoma College of Medicine
    Oklahoma City, Oklahoma, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.